We are live on
!
Find out more
CC
Colrain Capital Portfolio holdings
AUM
$259M
1-Year Est. Return
63.6%
This Fund
S&P 500
This Quarter
Est. Return
+1.64%
1 Year Est. Return
+63.6%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$90.9M
AUM Growth
+$1.8M
(+2%)
Cap. Flow
+$998K
Cap. Flow
% of AUM
1.1%
Top 10 Holdings %
Top 10 Hldgs %
59.91%
Holding
42
New
–
Increased
13
Reduced
7
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
The Mosaic Company
MOS
|
+$1.1M |
| 2 |
AbbVie
ABBV
|
+$1.08M |
| 3 |
CVS Health
CVS
|
+$400K |
| 4 |
SLB Ltd
SLB
|
+$274K |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$206K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bunge Global
BG
|
+$1.06M |
| 2 |
VanEck Oil Services ETF
OIH
|
+$302K |
| 3 |
Pfizer
PFE
|
+$299K |
| 4 |
UnitedHealth
UNH
|
+$241K |
| 5 |
Travelers Companies
TRV
|
+$149K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.56% |
| 2 | Technology | 20.55% |
| 3 | Communication Services | 11.79% |
| 4 | Materials | 9.81% |
| 5 | Financials | 8.07% |
Similar funds
NAM
CCAM
QP
BFA
PW
BFP
TC
FC
Colrain Capital's Q3 2019 Portfolio in Review
As of Q3 2019, Colrain Capital held 42 positions worth $90.9M, up 2% from $89M the previous quarter. Its ten largest holdings account for 60% of the portfolio.
Trading was light in Q3 2019: portfolio turnover was 0%. Colrain Capital opened no new positions and made no exits, leaving the 42-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 22% a quarter earlier, followed by Technology and Communication Services.
- Colrain Capital added most to The Mosaic Company in Q3 2019, an estimated $1.1M increase.
- Colrain Capital's biggest Q3 2019 reduction was Bunge Global, cutting an estimated $1.06M.
- Colrain Capital's ten largest holdings make up 60% of its $90.9M portfolio in Q3 2019.
- Colrain Capital opened 0 new positions and closed 0 in Q3 2019.
- Colrain Capital's portfolio value rose 2% quarter-over-quarter to $90.9M.
Based on Colrain Capital's 13F filing for Q3 2019, filed 23 Oct 2019.